UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 13, 2009
NORTHFIELD LABORATORIES INC.
(Exact Name of Registrant as Specified in Charter)
| |
|
|
|
|
Delaware
(State or Other Jurisdiction of
Incorporation)
|
|
000-24050
(Commission File Number)
|
|
36-3378733
(IRS Employer Identification No.) |
1560 Sherman Avenue
Suite 1000
Evanston, Illinois 60201-4800
(Address of Principal Executive Offices and Zip Code)
(847) 864-3500
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01. Regulation FD Disclosure.
On March 13, 2009, Northfield Laboratories Inc. issued a press release announcing that it had
obtained a commitment to purchase shares of convertible preferred stock pursuant to a registered
direct offering.
The information in this Item 7.01 and the exhibit referenced in Item 9.01 below will not be
deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the
“Exchange Act”), or otherwise subject to the liabilities of such section, nor will such information
or exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933 or
the Exchange Act, except as may be expressly set forth by specific reference in such filing.
|
|
|
| Item 9.01 |
|
Financial Statements and Exhibits. |
| |
|
|
|
|
| Exhibit No. |
|
Description |
| |
|
|
|
|
| |
99.1 |
|
|
Press Release dated March 13, 2009. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| Dated: March 13, 2009 |
NORTHFIELD LABORATORIES INC.
|
|
| |
By: |
/s/ Jack J. Kogut
|
|
| |
|
Jack J. Kogut |
|
| |
|
Senior Vice President Administration |
|
| |